Table 3.
Patients With Cormorbid Conditions Eligible for Each Randomized Controlled Trial
| Saguenay Data Set | ||||
| Randomized Controlled Trial | Potential Sample* n | Eligible Patients†n | Eligible Patients With Comorbidity n (%) | No. of Chronic Conditions in Eligible Patients With Comorbidity‡ Mean ± SD |
| Appel et al14 | 944§ | 326§ | 290 (89) | 5.5 ± 3.3 |
| Hansson et al15 | 332 | 171 | 170 (99) | 8.2 ± 4.2 |
| Wing et al16 (age range 65–74 y) | 114 | 74 | 74 (100) | 9.7 ± 4.1 |
| Wing et al16 (age range 75–84 y) | 71 | 43 | 43 (100) | 10.7 ± 4.8 |
| ALLHAT study17(age range 55–64 y) | 107 | 105 | 104 (99) | 8.6 ± 4.6 |
| ALLHAT study17(age ≥ 65 y) | 210 | 207 | 207 (100) | 11.7 ± 5.3 |
| Sacks et al18 | 956§ | 372§ | 331 (89) | 5.8 ± 3.5 |
* Patients with hypertension meeting the specified age for the randomized controlled trial.
† After applying inclusion and exclusion criteria.
‡ Hypertension included.
§ Included patients with normal arterial tension.